
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
U.S. teenagers should not be included in any HIV vaccine research because the risks outweigh any benefits, a Food and Drug Administration panel has determined. While including adolescents in countries where HIV is more prevalent is justified because of the heightened infection risks facing those teenagers, the low HIV prevalence rate among U.S. teens does not warrant including them in clinical trials, the FDA says.
From our Sponsors
Most Popular
Plus: Featured Video